Correlation Between Protagonist Therapeutics and Pfizer
Can any of the company-specific risk be diversified away by investing in both Protagonist Therapeutics and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protagonist Therapeutics and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protagonist Therapeutics and Pfizer Inc, you can compare the effects of market volatilities on Protagonist Therapeutics and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protagonist Therapeutics with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protagonist Therapeutics and Pfizer.
Diversification Opportunities for Protagonist Therapeutics and Pfizer
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Protagonist and Pfizer is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Protagonist Therapeutics and Pfizer Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc and Protagonist Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protagonist Therapeutics are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc has no effect on the direction of Protagonist Therapeutics i.e., Protagonist Therapeutics and Pfizer go up and down completely randomly.
Pair Corralation between Protagonist Therapeutics and Pfizer
Given the investment horizon of 90 days Protagonist Therapeutics is expected to generate 1.74 times more return on investment than Pfizer. However, Protagonist Therapeutics is 1.74 times more volatile than Pfizer Inc. It trades about 0.06 of its potential returns per unit of risk. Pfizer Inc is currently generating about 0.04 per unit of risk. If you would invest 5,637 in Protagonist Therapeutics on June 10, 2025 and sell it today you would earn a total of 416.00 from holding Protagonist Therapeutics or generate 7.38% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 98.41% |
| Values | Daily Returns |
Protagonist Therapeutics vs. Pfizer Inc
Performance |
| Timeline |
| Protagonist Therapeutics |
| Pfizer Inc |
Protagonist Therapeutics and Pfizer Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Protagonist Therapeutics and Pfizer
The main advantage of trading using opposite Protagonist Therapeutics and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protagonist Therapeutics position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.| Protagonist Therapeutics vs. Pliant Therapeutics | Protagonist Therapeutics vs. Syndax Pharmaceuticals | Protagonist Therapeutics vs. Revolution Medicines | Protagonist Therapeutics vs. Viridian Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |